No Data
No Data
Medike (688079.SH): The chip products under development can be used in the ai siasun robot&automation field.
On December 10, Gelonghui reported that Medica (688079.SH) stated on the investor interactive platform that the company has chip products under development for the ai siasun robot&automation field, which have not yet entered mass production.
MediKey (688079.SH): The cumulative change in Shengsheng Jiamei Co., Ltd. has reached 1.0735%.
Gelonghui, December 9th | MediKay (688079.SH) announced that it has received a notification from its shareholder Fengsheng Jiamei regarding a shareholding change exceeding 1%, Fengsheng Jiamei reduced its shares by 1,043,017 shares through block trade on July 6, 2023; from November 21, 2024 to December 6, 2024, it reduced its shares by 3,265,388 shares through centralized bidding trading method, with a cumulative shareholding change ratio of 1.0735%. After this equity change, shareholder Fengsheng Jiamei holds 33,638,236 shares of the company, still being a shareholder of the company.
Meidi Technology (688079.SH): The complete acoustic layer solution for the ultrasonic under-display fingerprint recognition chip has achieved mass production.
On December 2, Glory reports that Mediatek (688079.SH) stated on the investor interaction platform that the company's ultrasonic under-screen fingerprint recognition chip complete acoustic layer solution has achieved mass production. For specific related information, please pay attention to the periodic reports published by the company.
Medikey (688079.SH): The RF chip BAW project, multi-channel chromatographic chip optical path layer and other products are under development and testing, and the full process of sample preparation has been achieved.
On November 25th, Gelonghui reported that Medike (688079.SH) stated on the investor interaction platform that since its listing, the company has been committed to enriching and perfecting its business structure. Based on its existing optical products, it has placed significant investments in fields such as semiconductor acousto-optics, semiconductor micro-nano circuits, semiconductor packaging and testing, and micro-nano optics. Currently, products such as the complete acoustic layer solution for ultrasonic fingerprint chips, the complete optical path solution for ambient light chip products, the complete optical path solution for CIS image sensors, and the wafer manufacturing and packaging for RF chip SAW have gradually achieved mass production. Additionally, projects for RF chip BAW and multi-channel color...
Meidikai (688079.SH): temporarily no applications related to optical chips for the product.
On November 25th, Gelonhui reported that Medikai (688079.SH) stated on the investor interaction platform that the company's products currently do not have any applications related to optical chips.
October 31st A-share investment lightning rod | Medikai: Shareholder Fengsheng Jiamei plans to reduce their shareholding by no more than 3%; *Special Treat Ningke: and the actual controller received a notice from the China Securities Regulatory Commission
Hontian shareholders Dawson Investment and Nord Technology plan to reduce their shareholdings by a total of no more than 5%; Meidikai's shareholder Fengsheng Jiamei plans to reduce its shareholding by no more than 3%; Chongqing Iron & Steel incurs a net loss of 1.35 billion yuan in the first three quarters; Risesun Real Estate Development incurs a net loss of 1.425 billion yuan in the first three quarters; Longi Green Energy Technology incurs a net loss of 6.505 billion yuan in the first three quarters; Kraussmaffei incurs a net loss of 1.079 billion yuan in the first three quarters; Ruitai Materials Technology terminates the planned restructuring; ST Ningke and the actual controller received a notice of filing from the China Securities Regulatory Commission.
No Data